Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson’s disease by inhibiting oxidative stress and neuroinflammation
Authors:
- 14 August 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-11
Abstract
Background Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by oxidative stress and neuroinflammation. Sofalcone (SFC), a chalcone derivative known for its antioxidative and anti-inflammatory properties, is widely used clinically as a gastric mucosa protective agent. However, its therapeutic potential in PD remains to be fully explored. In this study, we investigated the neuroprotective effects of SFC in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Methods and results We found that SFC ameliorated MPTP-induced motor impairments in mice, as assessed by the rotarod and wire tests. Moreover, SFC administration prevented the loss of dopaminergic neurons and striatal degeneration induced by MPTP. Subsequent investigations revealed that SFC reversed MPTP-induced downregulation of NRF2, reduced elevated levels of reactive oxygen species (ROS) and malondialdehyde (MDA), and increased total antioxidant capacity (TAOC). Furthermore, SFC suppressed MPTP-induced activation of microglia and astrocytes, downregulated the pro-inflammatory cytokine TNF-α, and upregulated the anti-inflammatory cytokine IL-4. Additionally, SFC ameliorated the MPTP-induced downregulation of phosphorylation of Akt at Ser473. Conclusions This study provides evidence for the neuroprotective effects of SFC, highlighting its antioxidative and anti-inflammatory properties and its role in Akt activation in the PD model. These findings underscore SFC’s potential as a promising therapeutic candidate for PD, warranting further clinical investigation.Keywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (CSTB2022NSCQ-BHX0022, CSTB2024NSCQ-LZX0008)
- National Natural Science Foundation of China (32371030)
- CQMU Program for Youth Innovation in Future Medicine (W0044)
This publication has 36 references indexed in Scilit:
- Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s diseaseCell Reports, 2023
- Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K/Akt/mTOR signaling pathwayJournal of Ethnopharmacology, 2021
- Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson’s DiseaseNeurochemical Research, 2020
- Parkinson's disease: From bench to bedsideRevue Neurologique, 2020
- Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activityEuropean Journal of Pharmacology, 2019
- Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s DiseaseMolecular Neurobiology, 2017
- Monoamine oxidase inhibitory activity of methoxy-substituted chalconesInternational Journal of Biological Macromolecules, 2017
- Tyrosine hydroxylase and regulation of dopamine synthesisArchives of Biochemistry and Biophysics, 2011
- Sofalcone, an anti-ulcer chalcone derivative, suppresses inflammatory crosstalk between macrophages and adipocytes and adipocyte differentiation: Implication of heme-oxygenase-1 inductionBiochemical and Biophysical Research Communications, 2009
- Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?Free Radical Biology and Medicine, 2008